CRVO: CervoMed Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 19.19
Enterprise Value ($M) 11.45
Book Value ($M) 45.64
Book Value / Share 5.53
Price / Book 0.42
NCAV ($M) 45.56
NCAV / Share 5.52
Price / NCAV 0.42

Profitability (mra)
Return on Invested Capital (ROIC) -0.26
Return on Assets (ROA) -1.20
Return on Equity (ROE) -1.62

Liquidity (mrq)
Quick Ratio 15.04
Current Ratio 15.04

Balance Sheet (mrq) ($M)
Current Assets 48.81
Assets 48.88
Liabilities 3.25
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Ra Capital Management, L.p.
01-13 13G/A AWM Investment Company, Inc.
03-06 13G/A AI EIPP Holdings LLC 0.74 -90.06
02-28 13D/A Boger Joshua S 17.10 88.36

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 4,518 31,962 14.14
2025-02-20 15,369 73,450 20.92
2025-02-19 39,635 153,137 25.88
2025-02-18 14,526 94,568 15.36

(click for more detail)

Similar Companies
CRBP – Corbus Pharmaceuticals Holdings, Inc. CRDF – Cardiff Oncology, Inc.
CRIS – Curis, Inc. CSBR – Champions Oncology, Inc.
CSCI – COSCIENS Biopharma Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.